Assessing the biocompatibility of degradable metallic materials: State-of-the-art and focus on the potential of genetic regulation

Acta Biomaterialia

Volumn 6, Issue 5, 2010, Pages 1800-1807

  Purnama, Agung ^a,b   Hermawan, Hendra ^a   Couet, Jacques ^b   Mantovani, Diego ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Biocompatibility; Degradable metallic materials; Degradation product; Degradation test; Genetic regulations

Indexed keywords

BIOCOMPATIBILITY; BIOMARKERS; DEGRADATION; GENE EXPRESSION; METALS; TESTING; TISSUE; TOXICITY;

CORROSION-RESISTANT; DEGRADABLE METALLIC MATERIAL; DEGRADATION PRODUCTS; DEGRADATION TEST; DESIGN DEVELOPMENT; DESIGN USE; GENETIC REGULATION; METALLIC BIOMATERIALS; METALLIC MATERIAL; STATE OF THE ART;

CORROSION RESISTANCE;

ALLOY; BIOLOGICAL MARKER; DNA; INTERLEUKIN 1; IRON; MAGNESIUM; MATRIX METALLOPROTEINASE; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA; BIOMATERIAL; METAL;

BIOCOMPATIBILITY; BIODEGRADABLE IMPLANT; CELL CYCLE REGULATION; CELL FUNCTION; CORROSION; DNA DAMAGE; DOWN REGULATION; GENETIC REGULATION; HUMAN; INFLAMMATION; METAL IMPLANTATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR SUPPRESSOR GENE; UPREGULATION; VASCULAR SMOOTH MUSCLE; ANIMAL; DRUG EFFECT; GENE EXPRESSION REGULATION; MATERIALS TESTING; METHODOLOGY;

ANIMALS; BIOCOMPATIBLE MATERIALS; CORROSION; GENE EXPRESSION REGULATION; HUMANS; MATERIALS TESTING; METALS;

EID: 77954682989     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2010.02.027     Document Type: Review

References (84)

1. R.E. Stack, R.M. Califf, and H.R. Phillips Interventional cardiac catheterization at Duke Medical Center Am J Cardiol 62 1988 3F 24F
2. H. Tamai, K. Igaki, E. Kyo, K. Kosuga, A. Kawashima, and S. Matsui Initial and 6-month results of biodegradable poly-l-lactid acid coronary sents in humans J Am Heart Assoc 102 2000 399 404
3. W.J. Van Der Giesen, M.A. Lincoff, R.S. Schwartz, H.M.M. Van Beusekom, P.W. Serruys, and D.R. Holmes Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries Circulation 94 1996 1690 1697
4. E.D. McBride Absorbable metal in bone surgery J Am Med Assoc 111 1938 2464 2467
5. B. Heublein, R. Rohde, V. Kaese, M. Niemeyer, W. Hartung, and A. Haverich Biocorrosion of magnesium alloys: a new principle in cadiovascular implant technology Heart 89 2003 651 656
6. J. Levesque, H. Hermawan, D. Dube, and D. Mantovani Design of a pseudo-physiological test bench specific to the development of biodegradable metallic biomaterials Acta Biomater 4 2008 284 295
7. F. Witte, V. Kaese, H. Haferkamp, E. Switzer, A.M. Linderberg, and C.J. Wirth In vivo corrosion of four magnesium alloys and the associated bone response Biomaterials 26 2005 3557 3563
8. Y. Xin, C. Liu, X. Zhang, G. Tang, X. Tian, and P.K. Chu Corrosion behaviour of biomedical AZ91 magnesium alloy in simulated body fluids J Mater Res 22 2007 2004 2011
9. C. Di Mario, H. Griffiths, O. Goktekin, N. Peeters, J. Verbist, and M. Bosiers Drug-eluting bioabsorbable magnesium stent J Interv Cardiol 17 2004 391 395
10. P. Peeters, M. Bosiers, J. Verbist, K. Deloose, and B. Heublein Preliminary results after application of absorbable metal stents in patients with critical limb ischemia J Endovasc Ther 12 2005 1 5
11. R. Waksman, R. Pakala, P. Kuchulakanti, R. Baffour, D. Hellingga, and R. Seabron Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries Catheter Cardiovasc Interv 68 2006 607 617
12. M. Peuster, P. Wohlsein, M. Brugmann, M. Ehlerding, K. Seidler, and C. Fink A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal-results 6-18 months after implantation into New Zealand white rabbits Heart 86 2001 563 569
13. M. Peuster, C. Hesse, T. Schloo, C. Fink, P. Beerbaum, and C.V. Schnakenburg Long term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta Biomaterials 27 2006 4955 4962
14. H. Hermawan, H. Alamdari, D. Mantovani, and D. Dube Iron-manganese: new class of degradable metallic biomaterials prepared by powder metallurgy Powder Metall 51 2008 38 45
15. Schinhammer M, Hanzi AC, Loffler JF, Uggowitzer PJ. Design strategy for biodegradable Fe-based alloys for medical applications. Acta Biomater 2009. doi:10.1016/j.actbio.2009.1007.1039.
16. J. Black Biological performance of biomaterials 1999 Marcel Dekker New York
17. S.W. Shalaby, K.J.L. Burg, Absorbable and biodegradable polymers 2004 CRC Press New York
18. J. Vormann Magnesium: nutrition and metabolism Mol Aspects Med 24 2003 27 37
19. I.A. Mjor, A.H. Pettersen, and O. Skogedal Biological evaluation of filling materials: a comparison of results using cell culture techniques, implantation tests and pulp studies Int Dent J 27 1977 124 129
20. B.L. Mordike, and T. Ebert Magnesium: properties-application-potential Mater Sci Eng A 302 2001 37 45
21. M.M. Avedesian, and H. Baker Magnesium and magnesium alloys-ASM specialty handbook 1999 ASM International Materials Park, OH
22. J. Emsley The elements 1998 Clarendon Press Oxford
23. A. Hartwig Role of magnesium in genomic stability Mutat Res 475 2001 113 121
24. L. Li, J. Gao, and Y. Wang Evaluation of cytotoxicity and corrosion behavior of alkali-heat-treated magnesium in simulated body fluid Surf Coat Technol 185 2004 92 98
25. G. Song Control of biodegradation of biocompatible magnesium alloys Corr Sci 49 2007 1696 1701
26. Wang Y, Wei M, Gao J. Improve corrosion resistance of magnesium in simulated body fluid by dicalcium phosphate dihydrate coating. Mater Sci Eng 2008. doi:10.1016/j.msec.2008.09.051.
27. T.D. Lucey, and B. Venugopal Metal toxicity in mammals 1977 Plenum Press New York
28. J. Crossgrove, and W. Zheng Review article: manganese toxicity upon overoxposure NMR Biomed 17 2004 544 553
29. Z. Li, X. Gu, S. Lou, and Y. Zheng The development of binary Mg-Ca alloys for use as biodegradable materials within bones Biomaterials 29 2008 1329 1344
30. M. Fontcave, and J.L. Pierre Iron: metabolism, toxicity and therapy Biochimie 73 1993 767 773
31. P.P. Mueller, T. May, A. Perz, H. Hauser, and M. Peuster Control of smooth muscle cell proliferation by ferrous iron Biomaterials 27 2006 2193 2200
32. G. Sangiorgi, G. Melzi, P. Agostoni, C. Cola, F. Clementi, and P. Romitelli Engineering aspects of stents design and their translation into clinical practice Ann Ist Super Sanit 43 2007 89 100
33. Zhu S, Huang N, Xu L, Zhang Y, Liu H, Sun H, Leng Y. Biocompatibility of pure iron: in vitro assessment of degradation kinetics and cytotoxicity on endothelial cells. Materi Sci Eng 2009. doi:10.1016/j.msec2008.12.019.
34. M.J. Allen, and N. Rushton Use of the CytoTox 96(TM) assay in routine biocompatibility testing in vitro Promega Notes Mag 45 1994 7 10
35. M. Peuster, C. Fink, and C.V. Schanakenburg Biocompatibility of corroding tungsten coils: in vitro assessment of degradation kinetics and cytotoxicity on human cells Biomaterials 24 2003 4057 4061
36. M. Cervinka, V. Puza, V. Hroch, and Z. Cervinkova In vitro cytotoxicity testing of metal alloys used in medicine: comparison of different approaches Toxicol in Vitro 8 1994 783 785
37. P. Ngamwongsatit, P.P. Banada, W. Panbangred, and A.K. Bhunia WST-1 based cell toxicity assay as a substitute for MTT based assay for rapid detection of toxigenic Bacillus species using CHO cell line J Microbiol Methods 73 2008 2112 2115
38. Y. Ren, and K.B.Z. Yang In vitro study of platelet adhesion on medical nickel-free stainless steel surface Mater Lett 59 2005 1785 1789
39. C. Mao, W. Zhao, C. Zhu, A. Zhu, J. Shen, and S. Lin In vitro studies of platelet adhesion on UV radiation-treated nylon surface Carbohydr Polym 59 2005 19 25
40. I. Dion, M. Lahaye, R. Salmon, C. Baquey, J.R. Monties, and P. Havlik Blood hemolysis by ceramics Biomaterials 14 1993 107 111
41. 4V alloy Biomaterials 14 1993 122 126
42. A.E. Engberg, K. Sandholm, F. Bexborn, J. Persson, B. Nilsson, and G. Lindahl Inhibition of complement activation on a model biomaterial surface by streptococcal M protein-derived peptides Biomaterials 30 2009 2653 2659
43. M.B. Gorbet, and M.V. Sefton Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets, and leukocytes Biomaterials 25 2004 5681 5703
44. M. Misoph, S. Schwender, and J. Babin-Ebell Response of the cellular immune system to cardiopulmonary bypass is dependent of the applied pump type and of the use of heparin-coated surfaces Thorac Cardiovasc Surg 46 1998 222 227
45. R. Remes, and D.F. Williams Immune response in biocompatibility Biomaterials 13 1992 731 743
46. P.R. Craddock, J. Fehr, A.P. Dalmasso, K.L. Brigham, and H.S. Jacob Haemodialysis leukopenia: pulmonary vascular leukostasis resulting from complement activation by dialyser membranes J Clin Invest 59 1977 879 888
47. G.S. Smith, and J.H. Lumsden Review of neutrophil adherence, chemotaxis, phagocytosis and killing Vet Immunol Immunopathol 4 1983 177 236
48. M. Kanno, H. Kawakami, S. Nagaoka, and S. Kubota Biocompatibility of fluorinated polyimide J Biomed Mater Res 60 2002 53 60
49. Y. Tabata, and Y. Ikada Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage Biomaterials 9 1988 356 362
50. A. Brandwood, K.L. Noble, and K. Schindhelm Phagocytosis of carbon particles by macrophage in vitro Biomaterials 13 1992 646 648
51. B.J. Greenspan, and P.E. Morrow The effect of in vitro and aerosol exposures to cadmium on phagocytosis by rat pulmonary macrophages Fundam Appl Toxicol 4 1984 48 57
52. U.M. Gross, and V. Strunz The interface of various glasses and glass ceramics with a bony implantation bed J Biomed Mater Res 19 1985 251 271
53. J.C. Heath The production of malignant tumours by cobalt in the rat Br J Cancer 10 1956 668 673
54. M. De Boeck, M. Kirsch-Volders, and D. Lison Cobalt and antimony: genotoxicity and carcinogenicity Mutat Res 533 2003 135 152
55. G.E. Wnek, and G.L. Bowlin Encyclopedia of biomaterials and biomedical engineering 2004 Marcel Dekker New York
56. M. Valko, C.J. Rhodes, J. Moncol, M. Izakovic, and M. Mazur Free radicals, metals and antioxidants in oxidative stress-induced cancer Chem Biol Interact 160 2006 1 40
57. Y. Knobel, M. Glei, K. Osswald, and B.L. Pool-Zobel Ferric iron increase ROS formation, modulates cell growth and enhances genotoxic damage by 4-hydroxynonenal in human colon tumor cells Toxicol in Vitro 20 2006 793 800
58. Y. Hu, G. Wang, G.Y.J. Chen, X. Fu, and S.Q. Yao Proteome analysis of Saccharomyces cerevisiae under metal stress by two-dimensional differential gel electrophoresis Electrophoresis 24 2003 1458 1470
59. S.J. Stohs, and D. Bagchi Oxidative mechanisms in the toxicity of metal ions Free Rad Biol Med 18 1995 321 336
60. N.I. Zelko, T.J. Mariani, and R.J. Folz Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2) and EC-SOD (SOD3) gene structure, evolution and expression Free Radic Biol Med 33 2002 337 349
61. S. Elchuri, T.D. Oberley, W. Qi, R.S. Eisenstein, L.J. Roberts, and H. Van Remmen CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life Oncogene 24 2005 367 380
62. H.C. Yang, B.S. Lim, and Y.K. Lee In vitro assessment of biocompatibility of biomaterials by using fluorescent yeast biosensor Curr Appl Phys 5 2005 444 448
63. H.Y. Ra, and W.C. Parks Control of matrix metalloproteinase catalytic activity Matrix Biol 26 2007 587 596
64. G. Pasterkamp, A.H. Schoneveld, D.J. Hijnen, D.P.V. De Kleijn, H. Teepen, and A.C. Van der Wal Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery Atherosclerosis 150 2000 245 253
65. J.F. Woessner Matrix metalloproteinases and their inhibitors in connective tissue remodelling FASEB J 5 1991 2145 2154
66. D.L. Laskin, and J.D. Laskin Role of macrophages and inflammatory mediators in chemically induced toxicity Toxicology 160 2001 111 118
67. N. Zempo, N. Koyama, R.D. Kenagy, H.J. Lea, and A.W. Clowes Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor Am Heart Assoc 16 1996 28 33
68. K.H. Vousden, and X. Lu Live or let die: the cell's response to p53 Nat Rev Cancer 2 2002 594 604
69. N.S. Mateo, M. Sanchez-Beato, J.C. Martinez, A. Orfao, J.L. Orradre, and M.A. Piris P53, Rb and bcl-2 expression during the cell cycle: a study in phytohaemagglutinin stimulated lymphocytes and microwave irradiated lymphoid tissue sections J Clin Pathol 48 1995 151 159
70. D.W. Meek The p53 response to DNA damage DNA Repair 3 2004 1049 1056
71. C. Meplan, K. Mann, and P. Hainaut Cadmium induces conformational modifications of wild-type p53 and supresses p53 response to DNA damage in cultured cells J Biol Chem 274 1999 31663 31670
72. S. Kato, T. Akagi, K. Sugimura, A. Kishida, and M. Akashi Evaluation of biological responses to polymeric biomaterials by RT-PCR analysis. IV: study of c-myc, c-fos and p53 mRNA expression Biomaterials 21 2000 521 527
73. T.G. Van Kooten, C.L. Klein, and C.J. Kirkpatrick Cell-cycle control in cell-biomaterial interaction: expression of p53 and Ki67 human umbilical vein endohelial cells in direct contact and extract testing of biomaterials J Biomed Mater Res 52 2000 199 209
74. A.Q. Ali, T.P. Kannan, A. Ahmad, and A.R. Samsudin In vitro genotoxicity tests for polyhydroxybutyrate: a synthetic biomaterial Toxicol in Vitro 22 2007 57 67
75. G. Fey, and A. Gauldie The acute phase response of the liver in inflammation Prog Liver Dis 9 1990 89 116
76. H. Baumann, and J. Gauldie Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation Mol Biol Med 7 1990 147 159
77. L.C. Keong, and A.S. Halim In vitro models in biocompatibility assessment for biomedical grade chitosan derivatives in wound management Int J Mol Sci 10 2009 1300 1313
78. T.J. Carty, and R.E. Laliberte The biochemistry and pharmacology of interleukins-1 and 6 Agents Actions 26 1989 391 393
79. M.A. Cardona, R.L. Simmons, and S.S. Kaplan TNF and IL-1 generation by human monocytes in response to biomaterials J Biomed Mater Res 26 1992 851 859
80. T. Shirai, H. Yamaguchi, H. Ito, C.W. Todd, and R.B. Wallace Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor Nature 313 1985 803 806
81. D. Penica, G.E. Nedwin, J.S. Hayflick, P.H. Seeburg, R. Derynck, and M.A. Palladino Human tumour necrosis factor: precursor structure, expression, and homology to lymphotoxin Nature 312 1984 724 729
82. K.M. Miller, and J.M. Anderson Human monocyte/macrophage activation and interleukin 1 generation by biomedical polymers J Biomed Mater Res 22 1988 713 731
83. S.M. Opal, and V.A. De Palo Anti-inflammatory cytokines Chest 117 2000 1162 1172
84. F.M. Huang, M.Y. Chou, and Y.C. Chang Dentin bonding agents induce c-fos and c-jun protooncogenes expression in human gingival fibroblasts Biomaterials 24 2003 157 163